Why the study?
Endomyocardial biopsy remains the invasive gold standard for detecting myocardial fibrosis, but recent advances in cardiac imaging techniques have enabled non-invasive tissue characterization of the myocardium.
Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Supports fibrosis assessment in AF/SCD risk stratification; leaves open prospective outcome trials before routine adoption.
Mandoli et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: